Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Works by Suzuki, Agena
Results: 7
1
2
Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging.
- Published in:
- Endocrine Journal, 2024, v. 71, n. 8, p. 767, doi. 10.1507/endocrj.EJ24-0005
- By:
- Publication type:
- Article
3
Clinical feasibility of remote intermittently scanned continuous glucose monitoring in coronavirus disease 2019 patients with and without diabetes during dexamethasone therapy.
- Published in:
- Endocrine Journal, 2022, v. 69, n. 5, p. 597, doi. 10.1507/endocrj.ej21-0540
- By:
- Publication type:
- Article
4
Increased glycated albumin levels in patients with acromegaly related to glucose fluctuation caused by growth hormone excess but not albumin metabolism.
- Published in:
- Endocrine Journal, 2022, v. 69, n. 3, p. 225, doi. 10.1507/endocrj.ej21-0439
- By:
- Publication type:
- Article
5
A case of adrenocortical adenoma harboring venous thrombus mimicking adrenal malignancy.
- Published in:
- Endocrine Journal, 2021, v. 68, n. 7, p. 857, doi. 10.1507/endocrj.ej20-0667
- By:
- Publication type:
- Article
6
ATP6AP2 is robustly expressed in pancreatic β cells and neuroendocrine tumors, and plays a role in maintaining cellular viability.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36265-3
- By:
- Publication type:
- Article
7
Evaluation of the relationship between hemodialysis-related glycemic variability and hormonal profiles in patients with type 2 diabetes on hemodialysis: a pilot study.
- Published in:
- Renal Replacement Therapy, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s41100-022-00429-0
- By:
- Publication type:
- Article